SFM
DYN icon

Sphera Funds Management’s Dyne Therapeutics DYN Stock Holding History

Sphera Funds Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43M Buy
199,594
+39,000
+24% +$725K 0.58% 59
2026
Q1 		$2.91M Sell
160,594
-232,300
-59% -$4.01M 0.46% 66
2025
Q4 		$7.69M Sell
392,894
-33,624
-8% -$637K 1.49% 19
2025
Q3 		$5.4M Buy
426,518
+205,102
+93% +$2.34M 1.14% 26
2025
Q2 		$2.11M Sell
221,416
-107,846
-33% -$1.19M 0.49% 64
2025
Q1 		$3.44M Buy
329,262
+93,000
+39% +$1.33M 0.79% 38
2024
Q4 		$5.57M Buy
236,262
+179,758
+318% +$5.32M 1.01% 35
2024
Q3 		$2.03M Buy
+56,504
New +$2.25M 0.32% 83
2023
Q3 		– Sell
-119,918
Closed -$1.35M – 91
2023
Q2 		$1.35M Sell
119,918
-99,398
-45% -$1.17M 0.21% 80
2023
Q1 		$2.53M Buy
219,316
+212,167
+2,968% +$2.76M 0.42% 58
2022
Q4 		$82.9K Buy
+7,149
New +$82.7K 0.02% 62
2022
Q1 		– Sell
-105,204
Closed -$1.25M – 79
2021
Q4 		$1.25M Sell
105,204
-119,879
-53% -$1.68M 0.14% 82
2021
Q3 		$3.65M Sell
225,083
-144,631
-39% -$2.56M 0.31% 78
2021
Q2 		$7.78M Sell
369,714
-80,350
-18% -$1.51M 0.53% 55
2021
Q1 		$6.99M Buy
450,064
+350,064
+350% +$6.77M 0.54% 56
2020
Q4 		$2.1M Buy
100,000
+30,000
+43% +$593K 0.19% 85
2020
Q3 		$1.41M Buy
+70,000
New +$1.54M 0.14% 83

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sphera Funds Management's DYN Position: Q2 2026 in Review

Sphera Funds Management increased its Dyne Therapeutics (DYN) stake by 24% in Q2 2026, buying an estimated $725K and bringing the position to 199,594 shares worth $4.43M. The position accounts for 0.58% of the portfolio, ranked #59.

Sphera Funds Management first reported a position in DYN in Q3 2020 and has held it in 17 quarters since. The position peaked at $7.78M in Q2 2021. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Sphera Funds Management held 199,594 shares of Dyne Therapeutics worth $4.43M as of Q2 2026.
  • Sphera Funds Management bought 39,000 Dyne Therapeutics shares in Q2 2026, an estimated $725K.
  • Dyne Therapeutics made up 0.58% of Sphera Funds Management's portfolio in Q2 2026, its #59 holding.
  • Sphera Funds Management first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • Sphera Funds Management's Dyne Therapeutics position peaked at $7.78M in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.